Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

BACKGROUND: Although serotonin reuptake inhibitors are effective in the treatment of OCD, many patients fail to respond to these agents. Growing evidence from open-label and placebo-controlled trials suggests a role for augmentation of SRIs with atypical antipsychotics in OCD. Quetiapine is generall...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Psychiatry
Autores principales: Carey, Paul D, Vythilingum, Bavanisha, Seedat, Soraya, Muller, Jacqueline E, van Ameringen, Michael, Stein, Dan J
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2005
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC547907/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15667657/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-244X-5-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares